Quantcast

Renal denervation for resistant hypertension.

Research paper by Manuel de Sousa Mde S Almeida, Pedro de Araújo Pde A Gonçalves, Eduardo Infante de EI Oliveira, Henrique Cyrne de HC Carvalho

Indexed on: 11 Feb '15Published on: 11 Feb '15Published in: Revista Portuguesa de Cardiologia



Abstract

There is a marked contrast between the high prevalence of hypertension and the low rates of adequate control. A subset of patients with suboptimal blood pressure control have drug-resistant hypertension, in the pathophysiology of which chronic sympathetic hyperactivation is significantly involved. Sympathetic renal denervation has recently emerged as a device-based treatment for resistant hypertension. In this review, the pathophysiological mechanisms linking the sympathetic nervous system and cardiovascular disease are reviewed, focusing on resistant hypertension and the role of sympathetic renal denervation. An update on experimental and clinical results is provided, along with potential future indications for this device-based technique in other cardiovascular diseases.